{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T05:07:31Z","timestamp":1773032851535,"version":"3.50.1"},"reference-count":48,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["RO1 DK096137 (MDB)"],"award-info":[{"award-number":["RO1 DK096137 (MDB)"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Schlafen 12 (SLFN12) is an intermediate human Schlafen that induces differentiation in enterocytes, prostate, and breast cancer. We hypothesized that SLFN12 influences lung cancer biology. We investigated survival differences in high versus low SLFN12-expressing tumors in two databases. We then adenovirally overexpressed SLFN12 (AdSLFN12) in HCC827, H23, and H1975 cells to model lung adenocarcinoma (LUAD), and in H2170 and HTB-182 cells representing lung squamous cell carcinoma (LUSC). We analyzed proliferation using a colorimetric assay, mRNA expression by RT-qPCR, and protein by Western blot. To further explore the functional relevance of SLFN12, we correlated SLFN12 with seventeen functional oncogenic gene signatures in human tumors. Low tumoral SLFN12 expression predicted worse survival in LUAD patients, but not in LUSC. AdSLFN12 modulated expression of SCGB1A1, SFTPC, HOPX, CK-5, CDH1, and P63 in a complex fashion in these cells. AdSLFN12 reduced proliferation in all LUAD cell lines, but not in LUSC cells. SLFN12 expression inversely correlated with expression of a myc-associated gene signature in LUAD, but not LUSC tumors. SLFN12 overexpression reduced c-myc protein in LUAD cell lines but not in LUSC, by inhibiting c-myc translation. Our results suggest SLFN12 improves prognosis in LUAD in part via a c-myc-dependent slowing of proliferation.<\/jats:p>","DOI":"10.3390\/cancers12102738","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T04:18:57Z","timestamp":1600921137000},"page":"2738","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Schlafen 12 Is Prognostically Favorable and Reduces C-Myc and Proliferation in Lung Adenocarcinoma but Not in Lung Squamous Cell Carcinoma"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8809-9804","authenticated-orcid":false,"given":"Sarmad","family":"Al-Marsoummi","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, School of Medicine and the Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2752-2565","authenticated-orcid":false,"given":"Jonathan","family":"Pacella","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Medicine and the Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaylee","family":"Dockter","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Medicine and the Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Soderberg","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Medicine and the Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep K.","family":"Singhal","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine and the Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3818-5330","authenticated-orcid":false,"given":"Emilie E.","family":"Vomhof-DeKrey","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Medicine and the Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA"},{"name":"Department of Surgery, School of Medicine and the Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9696-2789","authenticated-orcid":false,"given":"Marc D.","family":"Basson","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, School of Medicine and the Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA"},{"name":"Department of Pathology, School of Medicine and the Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA"},{"name":"Department of Surgery, School of Medicine and the Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,24]]},"reference":[{"key":"ref_1","unstructured":"(2019, December 05). Cancer Fact Sheet, WHO. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: Current therapies and new targeted treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc3775","article-title":"Non-small-cell lung cancers: A heterogeneous set of diseases","volume":"14","author":"Chen","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International association for the study of lung cancer\/american thoracic society\/european respiratory society international multidisciplinary classification of lung adenocarcinoma","volume":"6","author":"Travis","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"ref_5","unstructured":"Yang, X., Peng, R., Peng, H., Zhang, Q., Long, G., Wu, G., and Liang, Z. (2019, February 05). The Association between SLFN5 Expression and the Prognosis of Non-Small Cell Lung Cancer. Available online: www.ijcem.com\/."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"172630","DOI":"10.1016\/j.ejphar.2019.172630","article-title":"Overexpression of SLFN5 induced the epithelial-mesenchymal transition in human lung cancer cell line A549 through \u03b2-catenin\/Snail\/E-cadherin pathway","volume":"862","author":"Guo","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.21037\/tlcr.2018.11.06","article-title":"Schlafen-11 (SLFN11): A step forward towards personalized medicine in small-cell lung cancer?","volume":"7","author":"Inno","year":"2018","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"76534","DOI":"10.18632\/oncotarget.12266","article-title":"Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition","volume":"7","author":"Murai","year":"2016","journal-title":"Oncotarget"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1200\/JCO.2018.77.7672","article-title":"Randomized, Double-Blind, Phase II Study of Temozolomide in Combination with Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer","volume":"36","author":"Pietanza","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1074-7613(00)80663-9","article-title":"Schlafen, a New Family of Growth Regulatory Genes that Affect Thymocyte Development","volume":"9","author":"Katayama","year":"1998","journal-title":"Immunity"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1159\/000492019","article-title":"Schlafen 12 Interaction with SerpinB12 and Deubiquitylases Drives Human Enterocyte Differentiation","volume":"48","author":"Basson","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_12","first-page":"999","article-title":"Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation","volume":"53","author":"Basson","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jss.2014.03.069","article-title":"Schlafen 12 expression modulates prostate cancer cell differentiation","volume":"190","author":"Kovalenko","year":"2014","journal-title":"J. Surg. Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Gy\u0151rffy, B., Surowiak, P., Budczies, J., and L\u00e1nczky, A. (2013). Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0082241"},{"key":"ref_15","first-page":"725","article-title":"An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients","volume":"123","author":"Lanczky","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Zhang","year":"2017","journal-title":"Science"},{"key":"ref_17","unstructured":"(2020, February 18). Expression of SLFN12 in Lung Cancer\u2014The Human Protein Atlas, (n.d.). Available online: https:\/\/www.proteinatlas.org\/ENSG00000172123-SLFN12\/pathology\/lung+cancer\/LUAD."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1200\/JCO.2011.39.5624","article-title":"Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer Subtypes: A Pooled Analysis","volume":"30","author":"Ignatiadis","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1093\/bioinformatics\/btt492","article-title":"Strengths and limitations of microarray-based phenotype prediction: Lessons learned from the IMPROVER Diagnostic Signature Challenge","volume":"29","author":"Tarca","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.lungcan.2008.03.033","article-title":"Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes","volume":"63","author":"Kuner","year":"2009","journal-title":"Lung Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"609","DOI":"10.21873\/anticanres.13990","article-title":"C-myc Contributes to Malignancy of Lung Cancer: A Potential Anticancer Drug Target","volume":"40","author":"Chanvorachote","year":"2020","journal-title":"Anticancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1515\/bmc.2011.018","article-title":"From mammals to viruses: The Schlafen genes in developmental, proliferative and immune processes","volume":"2","year":"2011","journal-title":"Biomol. Concepts"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1089\/jir.2012.0133","article-title":"The Schlafen Family of Proteins and Their Regulation by Interferons","volume":"33","author":"Mavrommatis","year":"2013","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ccell.2017.01.006","article-title":"Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis","volume":"31","author":"Gardner","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2019.03.004","article-title":"SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT\/GSK-3\u03b2\/\u03b2-catenin pathway","volume":"59","author":"Wan","year":"2019","journal-title":"Cell. Signal."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbrc.2008.03.032","article-title":"Subcellular localization of the Schlafen protein family","volume":"370","author":"Neumann","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0016-5085(18)31014-X","article-title":"912-Schlafen 12 Promotes Human Intestinal Epithelial Differentiation via Serpin B12 Modulation of the Deubiquitylation of Transcription Factors Such as CDX2","volume":"154","author":"Basson","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_28","first-page":"102","article-title":"Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics","volume":"12","author":"Lewis","year":"2015","journal-title":"Nat. Methods"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yexcr.2017.10.032","article-title":"Targeting tumor cells based on Phosphodiesterase 3A expression","volume":"361","author":"Nazir","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/dc.20975","article-title":"Value of P63 and CK5\/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens","volume":"37","author":"Khayyata","year":"2009","journal-title":"Diagn. Cytopathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1038\/sj.onc.1209442","article-title":"Identification of tumor markers and differentiation markers for molecular diagnosis of lung adenocarcinoma","volume":"25","author":"Nakamura","year":"2006","journal-title":"Oncogene"},{"key":"ref_32","first-page":"475","article-title":"Overexpression of CC10 modifies neoplastic potential in lung cancer cells","volume":"9","author":"Szabo","year":"1998","journal-title":"Cell Growth Differ. Mol. Biol. J. Am. Assoc. Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1749-6632.2000.tb05534.x","article-title":"The role of CC10 in pulmonary carcinogenesis: From a marker to tumor suppression","volume":"923","author":"Linnoila","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1080\/21691401.2019.1648283","article-title":"MiR-629-3p-induced downregulation of SFTPC promotes cell proliferation and predicts poor survival in lung adenocarcinoma","volume":"47","author":"Li","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/path.4469","article-title":"HOPX is methylated and exerts tumour-suppressive function through Ras-induced senescence in human lung cancer","volume":"235","author":"Chen","year":"2014","journal-title":"J. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.3892\/or.2017.5897","article-title":"Knockdown of c-Myc activates Fas-mediated apoptosis and sensitizes A549 cells to radiation","volume":"38","author":"Zhang","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbagrm.2014.03.013","article-title":"Myc and cell cycle control","volume":"1849","author":"Bretones","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA) Bioenerg."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","article-title":"The c-Myc target gene network","volume":"16","author":"Dang","year":"2006","journal-title":"Semin. Cancer Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-230X(02)84004-0","article-title":"The myc Oncogene: Omplex","volume":"84","author":"Oster","year":"2002","journal-title":"Adv. Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.yexcr.2010.03.025","article-title":"The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy","volume":"316","author":"Larsson","year":"2010","journal-title":"Exp. Cell Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1038\/sj.onc.1202746","article-title":"MYC oncogenes and human neoplastic disease","volume":"18","author":"Tersak","year":"1999","journal-title":"Oncogene"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cell.2012.08.026","article-title":"Transcriptional Amplification in Tumor Cells with Elevated c-Myc","volume":"151","author":"Lin","year":"2012","journal-title":"Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-019-0773-y","article-title":"LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p\/c-Myc axis","volume":"12","author":"Hua","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.21037\/tlcr.2020.01.03","article-title":"A detailed smoking history and determination of MYC status predict response to checkpoint inhibitors in advanced non-small cell lung cancer","volume":"9","author":"Chiu","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Rapp, U.R., Korn, C., Ceteci, F., Karreman, C., Luetkenhaus, K., Serafin, V., Zanucco, E., Castro, I., and Potapenko, T. (2009). Myc Is a Metastasis Gene for Non-Small-Cell Lung Cancer. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006029"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.18632\/oncotarget.26940","article-title":"Comparing progression molecular mechanisms between lung adenocarcinoma and lung squamous cell carcinoma based on genetic and epigenetic networks: Big data mining and genome-wide systems identification","volume":"10","author":"Yeh","year":"2019","journal-title":"Oncotarget"},{"key":"ref_47","first-page":"479","article-title":"Molecular biology of lung cancer","volume":"5","author":"Cooper","year":"2013","journal-title":"J. Thorac. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.14694\/EdBook_AM.2014.34.e497","article-title":"Taking on Challenging Targets: Making MYC Druggable","volume":"34","author":"Horiuchi","year":"2014","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/10\/2738\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:13:03Z","timestamp":1760177583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/10\/2738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,24]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["cancers12102738"],"URL":"https:\/\/doi.org\/10.3390\/cancers12102738","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,24]]}}}